These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18491424)

  • 1. [The design of clinical studies in neurooncology].
    Smolin AV; Kobiakov GL
    Zh Vopr Neirokhir Im N N Burdenko; 2008; (1):3-10. PubMed ID: 18491424
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical Trial Considerations in Neuro-oncology.
    Lee EQ
    Curr Treat Options Oncol; 2021 Jul; 22(9):78. PubMed ID: 34213625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects and perils of retrospective risk assessment of erythropoiesis-stimulating agents.
    Steensma DP
    Am J Hematol; 2008 Sep; 83(9):693-4. PubMed ID: 18615451
    [No Abstract]   [Full Text] [Related]  

  • 4. [Research methodology: A guarantee for progress in knowledge about infections].
    Carballo Alvarez F
    Rev Esp Quimioter; 2001 Jun; 14(2):126-37. PubMed ID: 11704767
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experimental research in hematology: planning, data management and the presentation of the results].
    Kulikov SM; Savchenko VG; Maslova ER; Parovichnikova EN; Gudulina IuIu
    Ter Arkh; 1996; 68(7):65-72. PubMed ID: 8928076
    [No Abstract]   [Full Text] [Related]  

  • 6. Research outcomes and recommendations for the assessment of progression in cancer clinical trials.
    Bushnell W; Stone A
    J Biopharm Stat; 2013; 23(5):949-50. PubMed ID: 23957508
    [No Abstract]   [Full Text] [Related]  

  • 7. Preferred designs, outcomes, and analysis strategies for treatment trials in idiopathic recurrent acute pancreatitis.
    Romagnuolo J; Guda N; Freeman M; Durkalski V
    Gastrointest Endosc; 2008 Nov; 68(5):966-74. PubMed ID: 18725158
    [No Abstract]   [Full Text] [Related]  

  • 8. The art of choosing sound study endpoints.
    Hanson B
    Injury; 2008 Jun; 39(6):656-8. PubMed ID: 18514657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpretation of clinical trial results.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S114-20. PubMed ID: 19007606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keeping faith with trial volunteers.
    Piccart M; Goldhirsch A; Wood W; Pritchard K; Baselga J; Reaby L; Kössler I; Kyriakides S; Norton L; Coates A
    Nature; 2007 Mar; 446(7132):137-8. PubMed ID: 17344833
    [No Abstract]   [Full Text] [Related]  

  • 11. [Randomization and comparison of final quality in clinical studies].
    Altman DG; Doré CJ
    Z Arztl Fortbild Qualitatssich; 2005; 99(10):629-34. PubMed ID: 16433266
    [No Abstract]   [Full Text] [Related]  

  • 12. Healing prayer outcomes studies: consensus recommendations.
    Dusek JA; Astin JA; Hibberd PL; Krucoff MW
    Altern Ther Health Med; 2003; 9(3 Suppl):A44-53. PubMed ID: 12776464
    [No Abstract]   [Full Text] [Related]  

  • 13. Health-related quality of life and cancer.
    Bottomley A
    Expert Rev Pharmacoecon Outcomes Res; 2009 Feb; 9(1):9-11. PubMed ID: 19371172
    [No Abstract]   [Full Text] [Related]  

  • 14. [Inclusion of health-related quality of life studies alongside clinical trials: basis and practical recommendations. Utilization of a check-list for their correct desing and evaluation].
    Soto Alvarez J
    An Med Interna; 2003 Dec; 20(12):633-44. PubMed ID: 14697086
    [No Abstract]   [Full Text] [Related]  

  • 15. CT2--the clinical trials control tower: overcoming barriers to opening oncology clinical trials.
    Hammond AL; Waller EK; Finkelstein LB
    J Clin Oncol; 2007 Apr; 25(10):1288; author reply 1288. PubMed ID: 17401022
    [No Abstract]   [Full Text] [Related]  

  • 16. Comments on 'Current issues in non-inferiority trials' by Thomas R. Fleming, Statistics in Medicine, DOI: 10.1002/sim.2855.
    Koch GG
    Stat Med; 2008 Feb; 27(3):333-42. PubMed ID: 17530625
    [No Abstract]   [Full Text] [Related]  

  • 17. Performing serial testing of treatment effects.
    Fleming TR; Green SJ; Harrington DP
    Experientia Suppl; 1982; 41():469-84. PubMed ID: 6958531
    [No Abstract]   [Full Text] [Related]  

  • 18. The importance of determining quality of life in clinical trials.
    Temple L; Fuzesi S; Patil S
    Surgery; 2009 Jun; 145(6):622-6. PubMed ID: 19486762
    [No Abstract]   [Full Text] [Related]  

  • 19. Large trials, small gains: is change on the way?
    Tuma RS
    J Natl Cancer Inst; 2010 Aug; 102(16):1216-17, 1223. PubMed ID: 20693460
    [No Abstract]   [Full Text] [Related]  

  • 20. Designing clinical trials in amyotrophic lateral sclerosis.
    Shefner JM
    Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):495-508, ix. PubMed ID: 18625412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.